Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma

Author： Adams Heiner Fritzsche Florian R Dirnhofer Stephan Kristiansen Glen Tzankov Alexandar

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.14, Iss.6, 2010-06, pp. : 577-584

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting class I histone deacetylases in cancer therapy

By Delcuve Geneviève P Khan Dilshad H Davie James R

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. : 29-41

Informa Healthcare

Access to resources Recommend Favorite

Novel Structural Insights into Class I and II Histone Deacetylases

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 235-240

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Histone Deacetylases in Neuroblastoma

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 436-447

Bentham Science Publishers

Access to resources Recommend Favorite

Assays for Histone Deacetylases

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

I. Hodgkin lymphoma: special challenges and solutions

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 21-24

John Wiley & Sons Inc

Access to resources Recommend Favorite